#cellbasedbioassays

For decades, cell-based assays have been used to determine how a particular drug, once administered, will affect an organism. They have emerged as an effective method for discovering biological drugs for pharmaceutical use. Cell-based assays can serve as a viable alternative for biological drug discovery that complements a variety of other technologies as well. Traditionally, cell-based assays had been used as a means for the secondary screening of new drugs. However, these days, assays are being used more and more frequently as the primary method of drug discovery and screening. This article provides an overview of cell-based assay and highlights some of the factors that can determine the success of an assay.

Every year, billions are invested by governments and businesses around the world for the clinical approval and testing of novel drug compounds. Despite this, the Food and Drug Administration (FDA) only approves a handful of new chemical entities for production and sale each year. For decades, cell-based bioassays have been used to streamline the process of drug discovery, testing, and development. These assays allow new drugs to be introduced into the market safely and efficiently. Due to their usefulness, the technological evolution of cell-based bioassays is not slowing down. This article talks about the various ways in which cell-based bioassays play a crucial and invaluable role in the process of drug discovery.